| Literature DB >> 23349805 |
Yuk-Sang Chan1, David S Huen, Ruth Glauert, Eleanor Whiteway, Steven Russell.
Abstract
Homing endonuclease gene (HEG) drive is a promising insect population control technique that employs meganucleases to impair the fitness of pest populations. Our previous studies showed that HEG drive was more difficult to achieve in Drosophila melanogaster than Anopheles gambiae and we therefore investigated ways of improving homing performance in Drosophila. We show that homing in Drosophila responds to increased expression of HEGs specifically during the spermatogonia stage and this could be achieved through improved construct design. We found that 3'-UTR choice was important to maximise expression levels, with HEG activity increasing as we employed Hsp70, SV40, vasa and βTub56D derived UTRs. We also searched for spermatogonium-specific promoters and found that the Rcd-1r promoter was able to drive specific expression at this stage. Since Rcd-1 is a regulator of differentiation in other species, it suggests that Rcd-1r may serve a similar role during spermatogonial differentiation in Drosophila. Contrary to expectations, a fragment containing the entire region between the TBPH gene and the bgcn translational start drove strong HEG expression only during late spermatogenesis rather than in the germline stem cells and spermatogonia as expected. We also observed that the fraction of targets undergoing homing was temperature-sensitive, falling nearly four-fold when the temperature was lowered to 18°C. Taken together, this study demonstrates how a few simple measures can lead to substantial improvements in the HEG-based gene drive strategy and reinforce the idea that the HEG approach may be widely applicable to a variety of insect control programs.Entities:
Mesh:
Substances:
Year: 2013 PMID: 23349805 PMCID: PMC3548849 DOI: 10.1371/journal.pone.0054130
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Figure 1Homing assay.
In this assay, donor and target constructs were placed at the same φC31 insertion site on homologous chromosomes (the donor and target chromosomes marked black and blue respectively). The target construct contains a GFP open reading frame (ORF) driven by an eye-specific promoter where the GFP ORF is split with an in-frame homing endonuclease recognition site (represented by adjacent green boxes). Transgenics bearing an intact target construct therefore exhibit GFP fluorescence in the eye. The donor construct has a homing endonuclease transcription unit is inserted into the HEG recognition site disrupting the GFP ORF and abolishing GFP fluorescence in the eye (loss of fluorescence represented by the GFP ORF being filled in white). Most constructs also include an RFP marker to allow the HEG insert to be tracked. Expression of the HEG in the germline causes cleavage of its recognition site in the target construct and subsequent repair leads to a number of different outcomes that can be differentiated by fluorescence and phenotypic markers as shown in the figure. The donor and target chromosomes are distinguished either with the linked cu marker (applicable with males only because of recombination) or a very closely linked mini-white marker within the donor construct (which is applicable to both sexes). It should be noted that NHEJ repair results in loss of GFP fluorescence in approximately two-thirds of cases only. The remaining third of NHEJ lesions can only be distinguished from unmodified targets by PCR and cleavage with I-SceI.
Summary of results of various promoter/3′-UTR combinations for transgenes at attP2.
| Promoter | 3′-UTR | Construct | GFP loss | Homing fraction | Fraction of targets homed |
|
|
|
| 70% (688/985) | 1% (1/94) | <1% |
|
|
|
| 61% (638/1041) | 0% (0/94) | Nil |
|
|
|
| 26% (78/296) | 78% (225/287) | 20% |
|
|
|
| 0% (0/55) | ND | ND |
| Native 3'-UTR |
| 2.8% (66/2326) | 64% (42/66) | 1.8% | |
|
|
| 9.1% (357/3910) | 69% (245/357) | 6.3% | |
|
|
|
| 1.9% (7/361) | ND | ND |
| SV40 early |
| 11% (210/1873) | 52% (110/210) | 5.9% | |
| Native 3'-UTR |
| 36% (328/911) | 48% (157/328) | 17% | |
|
|
| 33% (1234/3764) | 42% (523/1234) | 14% | |
|
|
|
| 5.5% (44/793) | 34% (15/44) | 1.9% |
|
|
| 53% (671/1272) | 38% (252/671) | 20% | |
|
|
|
| 19.0% (609/3198) | 31.5% (192/609) | 6.0% |
|
|
|
| 38% (417/1094) | 2% (2/94) | 1.8% |
|
|
| 70% (754/1083) | 6.2% (47/754) | 4.3% | |
|
|
|
| 58% (676/1162) | 0.3% (1/282) | ∼0.1% |
| Native 3'-UTR |
| 62% (1486/2385) | 0.3% (4/1486) | 0.2% | |
|
|
| 65% (642/992) | 0.5% (3/642) | 0.3% | |
|
|
|
| 37% (1273/3422) | 61% (782/1273) | 23% |
|
|
|
| 15% (395/2614) | 38% (152/395) | 5.8% |
|
|
|
| 14% (232/1612) | 12% (27/232) | 1.7% |
previously reported in [8].
ND: not done.
Homing performance is expression-limited.
| Transgene copy number | GFP loss | Home/GFP- | Fraction of targets homed |
| 1 copy | 37% (1273/3422) | 61% (782/1273) | 23% |
| 2 copies | 77% (901/1170) | 71% (636/901) | 54% |
attP2{Rcd-1r-HEG-2-βTub56D }.
attP40{ Rcd-1r-HEG-2-βTub56D }/+; attP2{Rcd-1r-HEG-2-βTub56D}/attP2{wDarkLime}.
Genome location and Rcd-1r-HEG-2-βTub56D transgene performance.
| Chromosomal band | GFP loss | Homing (as fraction ofGFP-negative targets) | Homing (as fraction of all targets) | Nearest genes |
|
| 39% (1467/3733) | 58% (846/1467) | 23% | Msp-300: ubiquitous |
|
| 53% (1541/2884) | 71% (1094/1541) | 38% | CR43622, CG33467:male-specific |
|
| 37% (1273/3422) | 61% (782/1273) | 23% | CG6310, Mocs: ubiquitous |
|
| 58% (2671/4573) | 58% (1538/2671) | 34% | Clc: ubiquitous |
extracted from Table 1.
Co-expression of Rcd-1r-HEG-βTub56D and bgcn-HEG-βTub56D.
| Construct | GFP-negative eventsarising from HR | GFP-negative eventsarising from NHEJ | GFP-positive |
|
| 23% (846/3733) | 17% (621/3733) | 61% (2266/3733) |
|
| 0.3% (3/992) | 64% (639/992) | 35% (350/992) |
| Both | 27% (296/1082) | 47% (507/1082) | 26% (279/1082) |
as fraction of all targets.
restated from Table 3.
restated from Table 1.
Ectopic homing.
| Construct | Target class | Donor | Acceptor | GFP loss | Homed events |
|
| Unpaired |
|
| 29% (302/1057) | 5 |
|
| Unpaired |
|
| 55% (181/327) | 3 |
|
| Unpaired |
|
| 67% (1810/2685) | 20 |
|
| Paired |
|
| 21% (628/3011) | 21 (10 of 41 crosses) |
as fraction of all targets. Figures for actual GFP-negative and total target counts follows.
previously reported in [8] and included here for ease of comparison.
Figure 2in situ hybridisation of I-SceI expression in Rcd-1r-driven transgenics.
The I-SceI transcript is clearly detected in the spermatogonial population of the testis (marked by adjacent black asterisk). In situ hybridisation was performed as described in [8].